You participated in a dedicated farewell online session for DT&IT PH on December 11, 2024. This gathering provided an opportunity to jointly reflect on our journey over the past year(s) together with peers. During this session, we focused on two main aspects: - Reviewing our business year 2024. - Farewelling our colleagues who are leaving, have already left, or are departing from our function or company in 2024. POAP dropped for Bayer DT&IT Pharma Design by stefankai with Canva POAP Terms & Conditions: https://bayer.com/poap Bayer IT POAP Collection: https://collections.poap.xyz/bayer-it/

You were invited to our Q4/2024 Townhall, where we explored our future organization based on what has been agreed upon until then. Updates from our Leadership Team included insights from the PH Strategy Summit, which did initiate discussions on our financials and the strategic mid- and long-term outcomes for Pharma. Additionally, we reflected on the results of the Ownership Pulse (formerly known as Employee Voice), discussed further considerations, and allocated time for a Q&A session. This token serves as appreciation for and proof of your participation. POAP dropped for Bayer DT&IT Pharma Design by stefankai with Canva POAP Terms & Conditions: https://bayer.com/poap Bayer IT POAP Collection: https://collections.poap.xyz/bayer-it/

Thank you for attending today's DT & IT Pharma Townhall! In today's meeting, we delved deeper into the successful launch of the Pharma Control Tower (go/PHCT), which serves as a central entry point for all your needs related to financial, operational stability, and governance for your applications, portfolios, and functions. Additionally, we shared some updates on the rollout of MyGenAssist at Pharma, highlighting our crucial role as key ambassadors. This past year has underscored the accelerated pace of innovation, with GenAI standing out as a prime example of the agility needed to proactively evolve our skill sets. Furthermore, we collectively reviewed our key priorities for 2024 and provided updates on our DSO learning journey. In summary: ///// PH Control Tower ///// Business priorities per department ///// MyGenAssist roll-out PH ///// DSO Champions update Bayer terms & conditions apply: https://www.bayer.com/en/poap-tc

Another DSO Open MIC session is in the books! Thank you for attending today's afternoon session. These sessions are a space for open exchanges about ongoing topics around DSO and an opportunity to share, ask questions, provide feedback, or just listen. Everyone is invited to attend, participation is voluntary, and the sessions will not be recorded. Bayer terms & conditions apply: https://www.bayer.com/poap-tc

Bringing DSO ways of working to R&D IT.

This time around we focussed on DSO, dynamic shared ownership. As we reflected on our expectations and shared our insightful opinions with our colleagues, we gained valuable feedback that we shall use for our common journey moving forward. Thank you.

Harnessing the power of data, the digital realm and AI, we have the ability to combat diseases and provide vital support to those in need! At today's collaborative open space gathering, our most commited intellects have united to explore fresh concepts and innovations. This environment empowered each and every one of us to think beyond what already is, fostering ambition and a shared sense of purpose among us. I eagerly await the fruitful outcomes of today's event and extend my deepest gratitude for all the invaluable contributions! Thank you. Art by Open AI's Dall-E